These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND DAXX, BING2, 1616, ENSG00000206206, MGC126246, Q9UER7, MGC126245, DAQB-126H3_2, DAP6 AND Prognosis
6488 results:

  • 1. Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome.
    Chen Y; Zhou D; Ma C; Cao J; Ying Q; Sheng L; Yan X; Ouyang G; Mu Q
    BMC Cancer; 2024 Nov; 24(1):1392. PubMed ID: 39533230
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review.
    Gao L; Fan J; He J; Fan W; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241285149. PubMed ID: 39512224
    [No Abstract]    [Full Text] [Related]  

  • 3.
    Wang JN; Ye B; Cheng F; Yang L; Hu Y; Zheng G; Cai Z; Yu J; Wu W
    Hematology; 2024 Dec; 29(1):2423324. PubMed ID: 39499083
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of Simultaneous Presence of Multiple PML-RARA Isoforms on Phenotype in Patients with Acute Promyelocytic Leukaemia.
    Goktas E; Zamani AG; Yildirim MS; Demircioglu S; Tekinalp A; Ceneli O
    J Coll Physicians Surg Pak; 2024 Nov; 34(11):1552-1556. PubMed ID: 39491447
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Research Progress on Prognostic Factors in Patients with Lower-Risk Myelodysplastic Syndrome--Review].
    Liu JN; Chen BA; Cheng J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1626-1630. PubMed ID: 39479859
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Diagnosis and Risk Stratification of Acute Myeloid leukemia, Myelodysplasia -Related].
    Yang H; Guo R; Shi Y; Qiao C; Wang Y; Wu YJ; Qiu HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1372-1376. PubMed ID: 39479818
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [The Effects of
    Shi XQ; Zhang PP; Guan YN; DU ZC; Chen Y; Huang P; He ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1365-1371. PubMed ID: 39479817
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical Characteristics and prognosis of Children with Hypodiploid B-cell Precursor Acute Lymphoblastic leukemia].
    Chen CX; Weng KZ; Wen H; Zhuang SQ; Wu XG; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1356-1364. PubMed ID: 39479816
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Association between Early Minimal Residual Disease Detected by Flow Cytometry and prognosis in Children with Acute Myeloid leukemia: A Clinical Retrospective Study].
    Lu WJ; Xiong H; Yang L; Long F; Chen Z; Tao F; Sun M; Wang Z; Luo LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1343-1348. PubMed ID: 39479814
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Expression and Clinical Significance of Serum HDAC2 in Patients with Acute Myeloid leukemia].
    Huang J; Yang JJ; Xu YC; Zhang HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1317-1322. PubMed ID: 39479811
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.
    Ghantous A; Nusslé SG; Nassar FJ; Spitz N; Novoloaca A; Krali O; Nickels E; Cahais V; Cuenin C; Roy R; Li S; Caron M; Lam D; Fransquet PD; Casement J; Strathdee G; Pearce MS; Hansen HM; Lee HH; Lee YS; de Smith AJ; Sinnett D; Håberg SE; McKay JA; Nordlund J; Magnus P; Dwyer T; Saffery R; Wiemels JL; Munthe-Kaas MC; Herceg Z
    Mol Cancer; 2024 Oct; 23(1):238. PubMed ID: 39443995
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Application of serum tumor specific protein 70 for prognostic stratification in acute myeloid leukemia].
    Huang YL; Jin F; Zhang LX; Mu Y; Lu FY; Xia WY; Zhu Q; Yang SX; Xu J; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Oct; 58(10):1541-1547. PubMed ID: 39428239
    [No Abstract]    [Full Text] [Related]  

  • 13. Prognostic impact of clonal hematopoiesis mutations at complete molecular remission in acute myeloid leukemia with NPM1 mutation.
    Wang L; Shu M; Zhang Z; Dou X; Xu X; Ma Y; Wen L; Yang X; Chen S
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):465. PubMed ID: 39422784
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Infection of Aspergillus fumigatus after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: 2 cases report and literature review].
    Zhao W; Chen M; Zhao YL
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):848-850. PubMed ID: 39414609
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeting USP14/UCHL5: A Breakthrough Approach to Overcoming Treatment-Resistant FLT3-ITD-Positive AML.
    Nogami A; Amemiya HJ; Fujiwara H; Umezawa Y; Tohda S; Nagao T
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408703
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Elucidating the role of MLL1 nsSNPs: Structural and functional alterations and their contribution to leukemia development.
    Al-Nakhle HH; Yagoub HS; Alrehaili RY; Shaqroon OA; Khan MK; Alsharif GS
    PLoS One; 2024; 19(10):e0304986. PubMed ID: 39405275
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. EGCG enhances antitumor effect of apatinib in nonsmall cell lung cancer by targeting VEGF signaling to inhibit glycolysis.
    Zhou Y; Qin L; Li C; Zhu D; Liu B
    Drug Dev Res; 2024 Nov; 85(7):e22239. PubMed ID: 39397333
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review.
    Ni Y; Li L; Wang Y; Sun L
    Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comprehensive multi-omics analysis of the prognostic value and immune signature of NCF2 in pan-cancer and its relationship with acute myeloid leukemia.
    Zhong F; Zeng Y; Yan Y; Guo L; Guo Q; Liu W; Liu C
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113364. PubMed ID: 39393272
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.
    Venton G; Colle J; Tichadou A; Quessada J; Baier C; Labiad Y; Perez M; De Lassus L; Loosveld M; Arnoux I; Abbou N; Ceylan I; Martin G; Costello R
    J Cell Mol Med; 2024 Oct; 28(19):e70011. PubMed ID: 39392121
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 325.